171 related articles for article (PubMed ID: 27241035)
1. ABO blood groups in relation to breast carcinoma incidence and associated prognostic factors in Moroccan women.
Zouine S; Marnissi F; Otmani N; Bennani Othmani M; El Wafi M; Kojok K; Zaid Y; Tahiri Jouti N; Habti N
Med Oncol; 2016 Jul; 33(7):67. PubMed ID: 27241035
[TBL] [Abstract][Full Text] [Related]
2. ABO blood type/Rh factor and the incidence and outcomes for patients with triple-negative breast cancer.
Yu J; Gao F; Klimberg VS; Margenthaler JA
Ann Surg Oncol; 2012 Oct; 19(10):3159-64. PubMed ID: 22878611
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of ABO blood types in young patients with breast cancer; a nationwide study in Korean Breast Cancer Society.
Park S; Kim KS; Kim JS; Han W; Park BW; Lee S; Jeon YW; Lee SK; Yu J; Lee JE; Kim SW; Nam SJ;
Med Oncol; 2017 Jun; 34(6):118. PubMed ID: 28500618
[TBL] [Abstract][Full Text] [Related]
4. ABO and Rh blood groups frequency in women with HER2 positive breast cancer.
Urun Y; Utkan G; Altundag K; Arslan O; Onur H; Arslan UY; Kocer M; Dogan I; Senler FC; Yalcin B; Demirkazik A; Akbulut H; Icli F
J BUON; 2012; 17(3):457-60. PubMed ID: 23033281
[TBL] [Abstract][Full Text] [Related]
5. Correlation of HER-2 over-expression with clinico-pathological parameters in Tunisian breast carcinoma.
Ayadi L; Khabir A; Amouri H; Karray S; Dammak A; Guermazi M; Boudawara T
World J Surg Oncol; 2008 Oct; 6():112. PubMed ID: 18945339
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Correlations between ABO Blood Group and Pre-Treatment Plasma Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiotherapy.
Peng H; Chen L; Li WF; Zhang Y; Liu LZ; Tian L; Lin AH; Sun Y; Ma J
PLoS One; 2016; 11(11):e0166194. PubMed ID: 27835689
[TBL] [Abstract][Full Text] [Related]
7. [Breast cancer in young patient in Morocco].
Znati K; Bennis S; Abbass F; Akasbi Y; Chbani L; Elfatemi H; Harmouch T; Amarti A
Gynecol Obstet Fertil; 2014 Mar; 42(3):149-54. PubMed ID: 22521987
[TBL] [Abstract][Full Text] [Related]
8. Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis.
St Romain P; Madan R; Tawfik OW; Damjanov I; Fan F
Hum Pathol; 2012 Mar; 43(3):398-404. PubMed ID: 21840040
[TBL] [Abstract][Full Text] [Related]
9. Risk of hepatocellular carcinoma in relation to ABO blood type.
Iavarone M; Della Corte C; Pelucchi C; Marconi M; Trotti R; Triolo M; Manini MA; La Vecchia C
Dig Liver Dis; 2016 Jan; 48(1):94-6. PubMed ID: 26611335
[TBL] [Abstract][Full Text] [Related]
10. The ABO blood group is an independent prognostic factor in patients with resected non-small cell lung cancer.
Fukumoto K; Taniguchi T; Usami N; Kawaguchi K; Fukui T; Ishiguro F; Nakamura S; Yokoi K
J Epidemiol; 2015; 25(2):110-6. PubMed ID: 25483106
[TBL] [Abstract][Full Text] [Related]
11. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand.
Shahi KS; Bhandari G; Singh A
J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737
[TBL] [Abstract][Full Text] [Related]
12. ABH and related histo-blood group antigens in normal & malignant human endometrium in relation to genetic and hormonal factors.
Skovlund VR
APMIS Suppl; 1997; 69():1-33. PubMed ID: 9254838
[TBL] [Abstract][Full Text] [Related]
13. A study of high-nuclear-grade breast cancer in Thailand: subclassification and correlation with prognostic factors and immunohistochemical study.
Chaiwun B; Nakrungsee S; Sukhamwang N; Srisukho S
Breast Cancer; 2010; 17(1):35-41. PubMed ID: 19789946
[TBL] [Abstract][Full Text] [Related]
14. ABO blood group and breast cancer incidence and survival.
Gates MA; Xu M; Chen WY; Kraft P; Hankinson SE; Wolpin BM
Int J Cancer; 2012 May; 130(9):2129-37. PubMed ID: 21633955
[TBL] [Abstract][Full Text] [Related]
15. Association of ABO blood types and clinicopathological features of ureteral transitional cell carcinoma in a single-center in China.
Huang H; Li X; Jin J
J Cancer Res Ther; 2016; 12(2):601-4. PubMed ID: 27461617
[TBL] [Abstract][Full Text] [Related]
16. Association of ABO blood group and breast cancer in Jodhpur.
Saxena S; Chawla VK; Gupta KK; Gaur KL
Indian J Physiol Pharmacol; 2015; 59(1):63-8. PubMed ID: 26571986
[TBL] [Abstract][Full Text] [Related]
17. HER2 as a prognostic factor in breast cancer.
Ménard S; Fortis S; Castiglioni F; Agresti R; Balsari A
Oncology; 2001; 61 Suppl 2():67-72. PubMed ID: 11694790
[TBL] [Abstract][Full Text] [Related]
18. Correlation between hormone receptor status and age, and its prognostic implications in breast cancer patients in Bahrain.
AlZaman AS; Mughal SA; AlZaman YS; AlZaman ES
Saudi Med J; 2016 Jan; 37(1):37-42. PubMed ID: 26739972
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status in invasive breast cancer: a 3,198 cases study at National Cancer Center, China.
Zhu X; Ying J; Wang F; Wang J; Yang H
Breast Cancer Res Treat; 2014 Oct; 147(3):551-5. PubMed ID: 25234844
[TBL] [Abstract][Full Text] [Related]
20. Course of breast cancer disease and ABO blood groups.
Munzarová M; Kovarík J; Hlávková J; Kolcová V
Biomed Pharmacother; 1985; 39(9-10):486-9. PubMed ID: 3833308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
